1W0Z | U:28-120,U:233-244; U:16-27,U:121-232 | UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1W10 | U:28-120,U:233-244; U:16-27,U:121-232 | UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1W11 | U:28-120,U:233-244; U:16-27,U:121-232 | UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1W12 | U:28-120,U:233-244; U:16-27,U:121-232 | UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1W13 | U:28-120,U:233-244; U:16-27,U:121-232 | UROKINASE TYPE PLASMINOGEN ACTIVATOR |
1W14 | U:28-120,U:233-244; U:16-27,U:121-232 | UROKINASE TYPE PLASMINOGEN ACTIVATOR |
2BVS | H:28-120,H:233-246; H:16-27,H:121-232 | HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL MOLECULES OCCUPYING THE S1 POCKET |
2BVX | H:28-120,H:233-246; H:16-27,H:121-232 | DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER |
2BXT | H:28-120,H:233-246; H:16-27,H:121-232 | DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER |
2BXU | H:28-120,H:233-246; H:16-27,H:121-232 | DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER |